Intrastriatal dopamine D1 antagonism dampens neural plasticity in response to motor cortex lesion

Neuroscience

Volumn 146, Issue 2, 2007, Pages 784-791

  Davis, E J H ^a,b   Coyne, C ^b   McNeill, T H ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

cortical ablation; SCH23390; striatum

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; GROWTH ASSOCIATED PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; DRUG MECHANISM; FORELIMB; MALE; MOTOR CORTEX; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSORIMOTOR FUNCTION; SIGNAL TRANSDUCTION; SYNAPTOGENESIS; UPREGULATION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BEHAVIOR, ANIMAL; BRAIN INJURIES; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; GAP-43 PROTEIN; GENE EXPRESSION REGULATION; MALE; MEMBRANE PROTEINS; MOTOR CORTEX; NEURONAL PLASTICITY; PSYCHOMOTOR PERFORMANCE; RATS; RATS, LONG-EVANS; TIME FACTORS;

EID: 34247236853     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.01.039     Document Type: Article

References (88)

1. Adkins D.L., Voorhies A.C., and Jones T.A. Behavioral and neuroplastic effects of focal endothelin-1 induced sensorimotor cortex lesions. Neuroscience 128 (2004) 473-486
2. Baldo B.A., Sadeghian K., Basso A.M., and Kelley A.E. Effects of selective dopamine D1 or D2 receptor blockade within nucleus accumbens subregions on ingestive behavior and associated motor activity. Behav Brain Res 137 (2002) 165-177
3. Beninger R.J., and Miller R. Dopamine D1-like receptors and reward-related incentive learning. Neurosci Biobehav Rev 22 (1998) 335-345
4. Beninger R.J., and Rolfe N.G. Dopamine D1-like receptor agonists impair responding for conditioned reward in rats. Behav Pharmacol 6 (1995) 785-793
5. Bjorklund A., and Hokfelt T. Classical transmitters in the CNS, part I Vol. 2 (1984), Elsevier, Amsterdam
6. Blandini F., Fancellu R., Orzi F., Conti G., Greco R., Tassorelli C., and Nappi G. Effects of the intrastriatal administration of selective dopaminergic agonists on Fos expression in the rat brain. Neurol Sci 23 Suppl 2 (2002) S57-S58
7. Blandini F., Fancellu R., Orzi F., Conti G., Greco R., Tassorelli C., and Nappi G. Selective stimulation of striatal dopamine receptors of the D1- or D2-class causes opposite changes of fos expression in the rat cerebral cortex. Eur J Neurosci 17 (2003) 763-770
8. Bouyer J.J., Park D.H., Joh T.H., and Pickel V.M. Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Res 302 (1984) 267-275
9. Boyeson M.G., and Feeney D.M. Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury. Pharmacol Biochem Behav 35 (1990) 497-501
10. Breitenstein C., Floel A., Korsukewitz C., Wailke S., Bushuven S., and Knecht S. A shift of paradigm: From noradrenergic to dopaminergic modulation of learning?. J Neurol Sci 248 (2006) 42-47
11. Breitenstein C., Korsukewitz C., Floel A., Kretzschmar T., Diederich K., and Knecht S. Tonic dopaminergic stimulation impairs associative learning in healthy subjects. Neuropsychopharmacology 31 (2006) 2552-2564
12. Bury S.D., and Jones T.A. Unilateral sensorimotor cortex lesions in adult rats facilitate motor skill learning with the "unaffected" forelimb and training-induced dendritic structural plasticity in the motor cortex. J Neurosci 22 (2002) 8597-8606
13. Butefisch C.M. Neurobiological bases of rehabilitation. Neurol Sci. 27 Suppl 1 (2006) S18-S23
14. Caine S.B., Heinrichs S.C., Coffin V.L., and Koob G.F. Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res 692 (1995) 47-56
15. Centonze D., Grande C., Saulle E., Martin A.B., Gubellini P., Pavon N., Pisani A., Bernardi G., Moratalla R., and Calabresi P. Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity. J Neurosci 23 (2003) 8506-8512
16. Centonze D., Gubellini P., Pisani A., Bernardi G., and Calabresi P. Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity. Rev Neurosci 14 (2003) 207-216
17. Centonze D., Gubellini P., Picconi B., Calabresi P., Giacomini P., and Bernardi G. Unilateral dopamine denervation blocks corticostriatal LTP. J Neurophysiol 82 (1999) 3575-3579
18. Centonze D., Picconi B., Gubellini P., Bernardi G., and Calabresi P. Dopaminergic control of synaptic plasticity in the dorsal striatum. Eur J Neurosci 13 (2001) 1071-1077
19. Cepeda C., Hurst R.S., Altemus K.L., Flores-Hernandez J., Calvert C.R., Jokel E.S., Grandy D.K., Low M.J., Rubinstein M., Ariano M.A., and Levine M.S. Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice. J Neurophysiol 85 (2001) 659-670
20. Cepeda C., and Levine M.S. Where do you think you are going?. The NMDA-D1 receptor trap. Sci STKE pe20 (2006)
21. Cheng H.W., Tong J., and McNeill T.H. Lesion-induced axon sprouting in the deafferented striatum of adult rat. Neurosci Lett 242 (1998) 69-72
22. Chou A.H., Zheng S., Itsukaichi T., and Howard B.D. Wnt-1 inhibits nerve growth factor-induced differentiation of PC12 cells by preventing the induction of some but not all late-response genes. Brain Res Mol Brain Res 77 (2000) 232-245
23. Cotman C.W., and Berchtold N.C. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 25 (2002) 295-301
24. Crisostomo E.A., Duncan P.W., Propst M., Dawson D.V., and Davis J.N. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol 23 (1988) 94-97
25. DiFiglia M., Roberts R.C., and Benowitz L.I. Immunoreactive GAP-43 in the neuropil of adult rat neostriatum: localization in unmyelinated fibers, axon terminals, and dendritic spines. J Comp Neurol 302 (1990) 992-1001
26. Di Paolo G., Lutjens R., Osen-Sand A., Sobel A., Catsicas S., and Grenningloh G. Differential distribution of stathmin and SCG10 in developing neurons in culture. J Neurosci Res 50 (1997) 1000-1009
27. Dunah A.W., and Standaert D.G. Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. J Neurosci 21 (2001) 5546-5558
28. Ebrahimi A., Pochet R., and Roger M. Topographical organization of the projections from physiologically identified areas of the motor cortex to the striatum in the rat. Neurosci Res 14 (1992) 39-60
29. Feeney D.M. From laboratory to clinic: noradrenergic enhancement of physical therapy for stroke or trauma patients. Adv Neurol 73 (1997) 383-394
30. Flores-Hernandez J., Cepeda C., Hernandez-Echeagaray E., Calvert C.R., Jokel E.S., Fienberg A.A., Greengard P., and Levine M.S. Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32. J Neurophysiol 88 (2002) 3010-3020
31. Gavet O., Ozon S., Manceau V., Lawler S., Curmi P., and Sobel A. The stathmin phosphoprotein family: intracellular localization and effects on the microtubule network. J Cell Sci 111 Pt 22 (1998) 3333-3346
32. Gladstone D.J., Danells C.J., Armesto A., McIlroy W.E., Staines W.R., Graham S.J., Herrmann N., Szalai J.P., and Black S.E. Physiotherapy coupled with dextroamphetamine for rehabilitation after hemiparetic stroke: a randomized, double-blind, placebo-controlled trial. Stroke 37 (2006) 179-185
33. Goldstein L.B. Pharmacology of recovery after stroke. Stroke 21 (1990) III139-III142
34. Goldstein L.B. Amphetamines and related drugs in motor recovery after stroke. Phys Med Rehabil Clin North Am 14 (2003) S125-S134 x
35. Gomez-Pinilla F., Ying Z., Roy R.R., Molteni R., and Edgerton V.R. Voluntary exercise induces a BDNF-mediated mechanism that promotes neuroplasticity. J Neurophysiol 88 (2002) 2187-2195
36. Gonzalez C.L., and Kolb B. A comparison of different models of stroke on behaviour and brain morphology. Eur J Neurosci 18 (2003) 1950-1962
37. Goslin K., Schreyer D.J., Skene J.H., and Banker G. Changes in the distribution of GAP-43 during the development of neuronal polarity. J Neurosci 10 (1990) 588-602
38. Groves P.M., Linder J.C., and Young S.J. 5-Hydroxydopamine-labeled dopaminergic axons: three-dimensional reconstructions of axons, synapses and postsynaptic targets in rat neostriatum. Neuroscience 58 (1994) 593-604
39. Hallett P.J., Spoelgen R., Hyman B.T., Standaert D.G., and Dunah A.W. Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking. J Neurosci 26 (2006) 4690-4700
40. Hersch S.M., Ciliax B.J., Gutekunst C.A., Rees H.D., Heilman C.J., Yung K.K., Bolam J.P., Ince E., Yi H., and Levey A.I. Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci 15 (1995) 5222-5237
41. Hughes-Davis E.J., Cogen J.P., Jakowec M.W., Cheng H.W., Grenningloh G., Meshul C.K., and McNeill T.H. Differential regulation of the growth-associated proteins GAP-43 and superior cervical ganglion 10 in response to lesions of the cortex and substantia nigra in the adult rat. Neuroscience 135 (2005) 1231-1239
42. Ivanco T.L., and Greenough W.T. Physiological consequences of morphologically detectable synaptic plasticity: potential uses for examining recovery following damage. Neuropharmacology 39 (2000) 765-776
43. Ivy A.S., Rodriguez F.G., Garcia C., Chen M.J., and Russo-Neustadt A.A. Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant. Pharmacol Biochem Behav 75 (2003) 81-88
44. Iwata S., Nomoto M., and Fukuda T. Quantification of neuromodulin (GAP-43, B-50) and synapsin I in rat striata. Nihon Shinkei Seishin Yakurigaku Zasshi 19 (1999) 261-266
45. Jacobs K.M., and Donoghue J.P. Reshaping the cortical motor map by unmasking latent intracortical connections. Science 251 (1991) 944-947
46. Johansson B.B. Brain plasticity and stroke rehabilitation. The Willis lecture. Stroke 31 (2000) 223-230
47. Keyvani K., and Schallert T. Plasticity-associated molecular and structural events in the injured brain. J Neuropathol Exp Neurol 61 (2002) 831-840
48. King C.E., Canty A.J., and Vickers J.C. Alterations in neurofilaments associated with reactive brain changes and axonal sprouting following acute physical injury to the rat neocortex. Neuropathol Appl Neurobiol 27 (2001) 115-126
49. Kleim J.A., Hogg T.M., VandenBerg P.M., Cooper N.R., Bruneau R., and Remple M. Cortical synaptogenesis and motor map reorganization occur during late, but not early, phase of motor skill learning. J Neurosci 24 (2004) 628-633
50. Kuzhikandathil E.V., and Oxford G.S. Classic D1 dopamine receptor antagonist R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzaze pine hydrochloride (SCH23390) directly inhibits G protein-coupled inwardly rectifying potassium channels. Mol Pharmacol 62 (2002) 119-126
51. Lei W., Jiao Y., Del Mar N., and Reiner A. Evidence for differential cortical input to direct pathway versus indirect pathway striatal projection neurons in rats. J Neurosci 24 (2004) 8289-8299
52. Li Y., Jiang N., Powers C., and Chopp M. Neuronal damage and plasticity identified by microtubule-associated protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats. Stroke 29 (1998) 1972-1980 discussion 1980-1981
53. Marklund U., Larsson N., Gradin H.M., Brattsand G., and Gullberg M. Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics. EMBO J 15 (1996) 5290-5298
54. McGeorge A.J., and Faull R.L. The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29 (1989) 503-537
55. McNeill T.H., Mori N., and Cheng H.W. Differential regulation of the growth-associated proteins, GAP-43 and SCG-10, in response to unilateral cortical ablation in adult rats. Neuroscience 90 (1999) 1349-1360
56. Meiri K.F., Bickerstaff L.E., and Schwob J.E. Monoclonal antibodies show that kinase C phosphorylation of GAP-43 during axonogenesis is both spatially and temporally restricted in vivo. J Cell Biol 112 (1991) 991-1005
57. Meshul C.K., Cogen J.P., Cheng H.W., Moore C., Krentz L., and McNeill T.H. Alterations in rat striatal glutamate synapses following a lesion of the cortico- and/or nigrostriatal pathway. Exp Neurol 165 (2000) 191-206
58. Millan M.J., Newman-Tancredi A., Quentric Y., and Cussac D. The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors. Psychopharmacology (Berl) 156 (2001) 58-62
59. Napieralski J.A., Butler A.K., and Chesselet M.F. Anatomical and functional evidence for lesion-specific sprouting of corticostriatal input in the adult rat. J Comp Neurol 373 (1996) 484-497
60. Nudo R.J., Plautz E.J., and Frost S.B. Role of adaptive plasticity in recovery of function after damage to motor cortex. Muscle Nerve 24 (2001) 1000-1019
61. Pei L., Lee F.J., Moszczynska A., Vukusic B., and Liu F. Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors. J Neurosci 24 (2004) 1149-1158
62. Perrone-Bizzozero N., and Bolognani F. Role of HuD and other RNA-binding proteins in neural development and plasticity. J Neurosci Res 68 (2002) 121-126
63. Platz T., Kim I.H., Engel U., Pinkowski C., Eickhof C., and Kutzner M. Amphetamine fails to facilitate motor performance and to enhance motor recovery among stroke patients with mild arm paresis: interim analysis and termination of a double blind, randomised, placebo-controlled trial. Restor Neurol Neurosci 23 (2005) 271-280
64. Plautz E.J., Milliken G.W., and Nudo R.J. Effects of repetitive motor training on movement representations in adult squirrel monkeys: role of use versus learning. Neurobiol Learn Mem 74 (2000) 27-55
65. Ranaldi R., Pantalony D., and Beninger R.J. The D1 agonist SKF 38393 attenuates amphetamine-produced enhancement of responding for conditioned reward in rats. Pharmacol Biochem Behav 52 (1995) 131-137
66. Reynolds J.N., Hyland B.I., and Wickens J.R. A cellular mechanism of reward-related learning. Nature 413 (2001) 67-70
67. Riederer B.M., Pellier V., Antonsson B., Di Paolo G., Stimpson S.A., Lutjens R., Catsicas S., and Grenningloh G. Regulation of microtubule dynamics by the neuronal growth-associated protein SCG10. Proc Natl Acad Sci U S A 94 (1997) 741-745
68. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., and Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39 (2000) 777-787
69. Scheidtmann K., Fries W., Muller F., and Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 358 (2001) 787-790
70. Self D.W., and Stein L. The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats. Brain Res 582 (1992) 349-352
71. Sheng M., and Greenberg M.E. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron 4 (1990) 477-485
72. Skene J.H., and Virag I. Posttranslational membrane attachment and dynamic fatty acylation of a neuronal growth cone protein, GAP-43. J Cell Biol 108 (1989) 613-624
73. Smith C.L., Afroz R., Bassell G.J., Furneaux H.M., Perrone-Bizzozero N.I., and Burry R.W. GAP-43 mRNA in growth cones is associated with HuD and ribosomes. J Neurobiol 61 (2004) 222-235
74. Smith Y., Bennett B.D., Bolam J.P., Parent A., and Sadikot A.F. Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey. J Comp Neurol 344 (1994) 1-19
75. Sonde L., Nordstrom M., Nilsson C.G., Lokk J., and Viitanen M. A double-blind placebo-controlled study of the effects of amphetamine and physiotherapy after stroke. Cerebrovasc Dis 12 (2001) 253-257
76. Stein R., Mori N., Matthews K., Lo L.C., and Anderson D.J. The NGF-inducible SCG10 mRNA encodes a novel membrane-bound protein present in growth cones and abundant in developing neurons. Neuron 1 (1988) 463-476
77. Stein R., Orit S., and Anderson D.J. The induction of a neural-specific gene, SCG10, by nerve growth factor in PC12 cells is transcriptional, protein synthesis dependent, and glucocorticoid inhibitable. Dev Biol 127 (1988) 316-325
78. Steiner H., and Kitai S.T. Regulation of rat cortex function by D1 dopamine receptors in the striatum. J Neurosci 20 (2000) 5449-5460
79. Steiner H., and Kitai S.T. Unilateral striatal dopamine depletion: time-dependent effects on cortical function and behavioural correlates. Eur J Neurosci 14 (2001) 1390-1404
80. Strittmatter S.M., Fankhauser C., Huang P.L., Mashimo H., and Fishman M.C. Neuronal pathfinding is abnormal in mice lacking the neuronal growth cone protein GAP-43. Cell 80 (1995) 445-452
81. Stroemer R.P., Kent T.A., and Hulsebosch C.E. Acute increase in expression of growth associated protein GAP-43 following cortical ischemia in rat. Neurosci Lett 162 (1993) 51-54
82. Stroemer R.P., Kent T.A., and Hulsebosch C.E. Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats. Stroke 29 (1998) 2381-2393 discussion 2393-2395
83. Swanson L.W. Brain maps: Structure of the rat brain (1998), Elsevier Science BV, Amsterdam, The Netherlands
84. Treig T., Werner C., Sachse M., and Hesse S. No benefit from D-amphetamine when added to physiotherapy after stroke: a randomized, placebo-controlled study. Clin Rehabil 17 (2003) 590-599
85. van Praag H., Kempermann G., and Gage F.H. Neural consequences of environmental enrichment. Nat Rev Neurosci 1 (2000) 191-198
86. Vargo J.M., Bromberg B.B., Best P.J., Corwin J.V., and Marshall J.F. D1-class dopamine receptor involvement in the behavioral recovery from prefrontal cortical injury. Behav Brain Res 72 (1995) 39-48
87. Walker-Batson D., Smith P., Curtis S., Unwin H., and Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke 26 (1995) 2254-2259
88. West A.R., Floresco S.B., Charara A., Rosenkranz J.A., and Grace A.A. Electrophysiological interactions between striatal glutamatergic and dopaminergic systems. Ann N Y Acad Sci 1003 (2003) 53-74